NCT01894477 2021-06-03
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Fred Hutchinson Cancer Center
Phase 2 Unknown
Clinical Trials
9 trialsNCT02852083 2018-01-18
ModuLung
University Hospital Regensburg
Phase 2 Unknown
NCT01079013 2016-04-20
Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies
Sheba Medical Center
Phase 2 Unknown
NCT01423500 2015-06-26
ALL-SCT-BFMi
St. Anna Kinderkrebsforschung
Phase 3 Unknown
NCT01423747 2015-06-26
Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia
St. Anna Kinderkrebsforschung
Phase 3 Unknown
NCT01810926 2013-03-14
T&B Depletion Non Malignant
Bambino Gesù Hospital and Research Institute
Phase 2 Unknown
NCT01010243 2012-05-30
MM03
University of Regensburg
Phase 1/2 Unknown
NCT00779714 2008-10-24
ChemoSensMM
University of Wuerzburg
Phase 3 Unknown
NCT00129155 2007-10-04
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Hospices Civils de Lyon
Phase 2 Unknown